comparemela.com
Home
Live Updates
Hat 9939 Kyg5273b1077 - Breaking News
Pages:
Hat 9939 Kyg5273b1077 News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Kintor Pharmaceutical : Pharma Announces Completion of Patient Enrollment in Phase II Clinical Trial of KX-826 for Acne Vulgaris in China
Suzhou, October 16, 2022 - Kintor Pharmaceutical Limited , a clinical-stage biotechnology company developing innovative small molecules and biological therapeutics, today announced that the. | October 16, 2022
Leihong xiang
Kintor pharma
Fudan university
Kintor pharmaceutical limited pharma
Pharmaceutical limited
Investigator global assessment
Youzhi tong
Chief executive officer
Professor leihong xiang
Huashan hospital
Kintor pharmaceutical limited stock exchange
Press release
Hat 9939 kyg5273b1077
vimarsana © 2020. All Rights Reserved.